SIBN (SI-BONE, Inc.) Stock Financials & Earnings

SIBNSI-BONE, Inc.

Mkt Cap$615M

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Revenue (TTM)$201M

Net Income (TTM)-$19M

EPS (TTM)-$0.44

Free Cash Flow (TTM)-$9M

Gross Margin79.6%

Op. Margin-11.1%

Net Margin-9.4%

FCF Margin-4.5%

P/S Ratio (TTM)3.1x

P/E Ratio (TTM)—

YoY Rev Growth+20.2%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$33M	$27M	-$11M
Q2 23	$33M	$27M	-$12M
Q3 23	$34M	$27M	-$11M
Q4 23	$39M	$29M	-$13M
Q1 24	$38M	$30M	-$12M
Q2 24	$40M	$32M	-$10M
Q3 24	$40M	$32M	-$8M
Q4 24	$49M	$39M	-$5M
Q1 25	$47M	$38M	-$7M
Q2 25	$49M	$39M	-$7M
Q3 25	$49M	$39M	-$5M
Q4 25	$56M	$45M	-$2M

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q1 23	$3M	$7M	$27M
Q2 23	$4M	$8M	$27M
Q3 23	$4M	$8M	$27M
Q4 23	$4M	$8M	$29M
Q1 24	$4M	$8M	$29M
Q2 24	$4M	$8M	$29M
Q3 24	$4M	$8M	$27M
Q4 24	$4M	$9M	$31M
Q1 25	$5M	$10M	$31M
Q2 25	$4M	$11M	$31M
Q3 25	$4M	$10M	$30M
Q4 25	$4M	$10M	$33M

Revenue by Geography

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$23M	$63M	$86M
Q2 23	$111M	$59M	$169M
Q3 23	$53M	$113M	$167M
Q4 23	$33M	$133M	$166M
Q1 24	$32M	$126M	$158M
Q2 24	$26M	$126M	$152M
Q3 24	$30M	$121M	$151M
Q4 24	$35M	$115M	$150M
Q1 25	$41M	$103M	$144M
Q2 25	$34M	$111M	$146M
Q3 25	$26M	$119M	$146M
Q4 25	$42M	$106M	$148M

Shares Outstanding

Revenue Per Employee

Revenue / Employee